Zydus Lifesciences, Granules India offer growth opportunities over next 3-5 years: Shanika Capital
CNBC-TV18

Shanika Capital highlights Zydus Lifesciences and Granules India as strong pharmaceutical growth prospects for the upcoming years.
Anmol Ganjoo of Shanika Capital has identified Zydus Lifesciences and Granules India as potential winners in the pharmaceutical sector. This positive outlook is based on anticipated earnings growth, effective capital allocation, and future business opportunities. According to the analysis, these two companies are positioned to offer significant growth opportunities over the next three to five years.
Why it matters: Identifying specific pharmaceutical companies with strong growth potential helps investors navigate market opportunities over the medium term.



